Literature DB >> 817853

Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency.

J S O'Brien, E Gugler, A Giedion, U Wiessmann, N Herschkowitz, C Meier, J Leroy.   

Abstract

A 14-year-old girl with a unique type of progressive spondyloepiphyseal dysplasia, corneal clouding, and no evidence of neurological abnormality, was found to have a remarkable deficiency of acid beta-galactosidase activity in cultured skin fibroblasts and in leucocyte preparations. In fibroblasts, ganglioside GM1 beta-galactosidase activity averaged 7% of the normal mean while asialofetuin beta-galactosidase and 4-methylumbe lifery-beta-galactosidase averaged 1.4% and 3.5%, respectively. Activities for all three substrates in leucocytes from both her parents were close to 50% of the normal mean indicating that the patient is homozygous for a mutation (or mutations) affecting GM1 beta-galactosidase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 817853     DOI: 10.1111/j.1399-0004.1976.tb01603.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  34 in total

1.  Morquio-B syndrome (MPS-IV B) associated with beta-galactosidase deficiency in two siblings.

Authors:  Jayesh J Sheth; Frenny J Sheth; Raktima Bhattacharya
Journal:  Indian J Pediatr       Date:  2002-01       Impact factor: 1.967

Review 2.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

3.  Spondylo-epiphyseal dysplasia with ocular changes: report of two "new" variants in two different families.

Authors:  J J MacDessi; K Kozlowski; S Posen
Journal:  Pediatr Radiol       Date:  1978-12-04

Review 4.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

Review 5.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

6.  Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.

Authors:  G M Mancini; A T Hoogeveen; H Galjaard; J E Mansson; L Svennerholm
Journal:  Hum Genet       Date:  1986-05       Impact factor: 4.132

7.  Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A).

Authors:  M Iwamoto; Y Nawa; I H Maumenee; J Young-Ramsaran; R Matalon; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

8.  The lesions of an ovine lysosomal storage disease. Initial characterization.

Authors:  R D Murnane; D J Prieur; A J Ahern-Rindell; S M Parish; L L Collier
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

9.  Nature of the mutation in adult beta-galactosidase deficient patients.

Authors:  J S O'Brien; A G Norden
Journal:  Am J Hum Genet       Date:  1977-03       Impact factor: 11.025

10.  Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.

Authors:  Katarzyna A Ellsworth; Laura M Pollard; Sara Cathey; Tim Wood
Journal:  JIMD Rep       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.